Natarajan Sethuraman
Chief Tech/Sci/R&D Officer bij ENTRADA THERAPEUTICS, INC.
Vermogen: 3 M $ op 31-03-2024
Profiel
Natarajan Sethuraman is currently the Chief Scientific Officer at Entrada Therapeutics, Inc. Previously, he worked at Merck & Co., Inc. as the Executive Director & Head-GlycoFi Site from 2012 to 2016.
He also worked as a Senior Scientist at Medical Enzymes AG.
Dr. Sethuraman received his graduate and doctorate degrees from the Indian Agricultural Research Institute and his undergraduate degree from Tamilnadu Agricultural University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ENTRADA THERAPEUTICS INC
0.62% | 05-03-2024 | 209 032 ( 0.62% ) | 3 M $ | 31-03-2024 |
Actieve functies van Natarajan Sethuraman
| Bedrijven | Functie | Begin |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-09-2017 |
Eerdere bekende functies van Natarajan Sethuraman
| Bedrijven | Functie | Einde |
|---|---|---|
| MERCK & CO., INC. | Director/Board Member | 01-07-2016 |
Medical Enzymes AG
 Medical Enzymes AG Medical/Nursing ServicesHealth Services Medical Enzymes AG is a privately held innovative biopharmaceutical company with a focus on therapeutically useful enzymes. The company has developed a new product family based on amino acid depleting enzymes. This unique approach is highly effective against cancer - the major target market of Medical Enzymes AG. Medical Enzymes business strategy focuses on the clinical development of therapeutic enzymes until clinical proof of concept and to commercialize those products through collaboration with selected pharmaceutical partners. | Corporate Officer/Principal | - |
Opleiding van Natarajan Sethuraman
| Indian Agricultural Research Institute | Doctorate Degree |
| Tamilnadu Agricultural University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| ENTRADA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Medical Enzymes AG
Medical Enzymes AG Medical/Nursing ServicesHealth Services Medical Enzymes AG is a privately held innovative biopharmaceutical company with a focus on therapeutically useful enzymes. The company has developed a new product family based on amino acid depleting enzymes. This unique approach is highly effective against cancer - the major target market of Medical Enzymes AG. Medical Enzymes business strategy focuses on the clinical development of therapeutic enzymes until clinical proof of concept and to commercialize those products through collaboration with selected pharmaceutical partners. | Health Services |
